Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor.
Lockhart AC, Braun RD, Yu D, Ross JR, Dewhirst MW, Humphrey JS, Thompson S, Williams KM, Klitzman B, Yuan F, Grichnik JM, Proia AD, Conway DA, Hurwitz HI.
Lockhart AC, et al. Among authors: dewhirst mw.
Clin Cancer Res. 2003 Feb;9(2):586-93.
Clin Cancer Res. 2003.
PMID: 12576422
Clinical Trial.